Repositioning Candidate Details
| Candidate ID: | R0601 |
| Source ID: | DB04348 |
| Source Type: | approved; experimental |
| Compound Type: | small molecule |
| Compound Name: | Taurocholic acid |
| Synonyms: | -- |
| Molecular Formula: | C26H45NO7S |
| SMILES: | [H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O |
| Structure: |
|
| DrugBank Description: | The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic. |
| CAS Number: | 81-24-3 |
| Molecular Weight: | 515.703 |
| DrugBank Indication: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | Bile salt-activated lipase; Bile acid receptor; Gastrotropin ligand |
| Inclusion Criteria: | Target associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|